ATHOS KG Amends Immatics N.V. (IMTX) Stake Filing

Ticker: IMTX · Form: SC 13G/A · Filed: Feb 7, 2024 · CIK: 1809196

Complexity: simple

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investing

TL;DR

**ATHOS KG still holds a big chunk of Immatics (IMTX), signaling continued institutional confidence.**

AI Summary

ATHOS KG, a German investment firm, has filed an amended SC 13G/A for Immatics N.V. (NASDAQ: IMTX) as of December 31, 2023. This filing indicates that ATHOS KG continues to hold a significant stake in Immatics, a biotechnology company focused on cancer immunotherapies. While the specific percentage of ownership isn't detailed in the provided excerpt, the filing confirms their ongoing beneficial ownership, which is important for investors as large institutional holdings can signal confidence in a company's long-term prospects.

Why It Matters

Large institutional ownership, like that of ATHOS KG, can provide stability and a vote of confidence in Immatics N.V., potentially influencing investor sentiment and stock price.

Risk Assessment

Risk Level: low — This is an amendment to a passive filing, indicating no immediate change in control or significant new risks.

Analyst Insight

Investors should note the continued institutional interest from ATHOS KG in Immatics N.V., which could be a positive signal, but this filing alone doesn't provide new actionable information beyond confirming existing ownership.

Key Players & Entities

Forward-Looking Statements

FAQ

What is the purpose of an SC 13G/A filing?

An SC 13G/A is an amendment to a Schedule 13G, which is filed by passive investors who own 5% or more of a company's stock. The '/A' indicates it's an amendment to a previously filed statement, updating information as of December 31, 2023, in this case.

Who is the reporting person in this filing?

The reporting person in this SC 13G/A filing is ATHOS KG, an entity organized in Germany, as stated on the cover page.

What is the subject company of this filing?

The subject company is Immatics N.V., identified by its CIK 0001809196 and CUSIP N44445109, with Ordinary Shares as the class of securities.

What was the 'Date of Event Which Requires Filing of this Statement'?

The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as specified on the cover page of the filing.

Under which rule was this Schedule 13G filed?

This Schedule 13G was filed under Rule 13d-1(d), as indicated by the checked box on the cover page.

Filing Stats: 1,210 words · 5 min read · ~4 pages · Grade level 11.8 · Accepted 2024-02-07 17:02:58

Filing Documents

From the Filing

SC 13G/A 1 d769663dsc13ga.htm SC 13G/A SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* IMMATICS N.V. (Name of Issuer) Ordinary Shares, nominal value 1.00 per share (Title of Class of Securities) N44445109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G CUSIP No. N44445109 1 NAME OF REPORTING PERSONS ATHOS KG 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Germany NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 4,911,278 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 4,911,278 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,911,278 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.8% 12 TYPE OF REPORTING PERSON (See Instructions) OO 2 SCHEDULE 13G CUSIP No. N44445109 1 NAME OF REPORTING PERSONS AT Impf GmbH 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Germany NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 4,911,278 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 4,911,278 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,911,278 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.8% 12 TYPE OF REPORTING PERSON (See Instructions) OO 3 SCHEDULE 13G CUSIP No. N44445109 1 NAME OF REPORTING PERSONS Thomas Maier 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Germany NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 4,911,278 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 4,911,278 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,911,278 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.8% 12 TYPE OF REPORTING PERSON (See Instructions) IN 4 Item1(a) Name of Issuer. The name of the issuer is Immatics N.V. (the Issuer ). Item1(b) Address of Issuers Principal Executive Offices. The Issuers principal executive office is located at Paul-Ehrlich-Straße 15, 72076 Tübingen, Germany. Item2(a) Name of Person Filing. This Amendment No. 1 to Schedule 13G is being jointly filed by ATHOS KG, AT Impf GmbH and Thomas Maier, each of the foregoing, a Reporting Person , and collectively, the Reporting Persons . The sole member of AT Impf GmbH is ATHOS KG and, as a result, ATHOS KG is deemed to be the beneficial owner of the securities held by AT Impf GmbH. Thomas Maier is the general partner ( komplementär) of ATHOS KG. The limited partners ( kommanditisten ) of ATHOS KG are members of the families of Thomas and Andreas Strüngmann. The Reporting Persons have entered into a Joint Filing Agreement, dated August 16, 2023, which was attached as Exhibit 1 to Schedule 13G filed by the Reporting Persons, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act. Item2(b) Address of Principal Business Office or, if none, Residence. The address of the principal business office of each of the Reporting Persons is Bergfeldstraße 9 83607 Holzkirchen. Item2(c) Citizenship. ATHOS KG is a German limited partnership ( Kommanditgesellschaft ); AT Impf GmbH is a German limited liability company ( Gesellschaft mit beschränkter Haftung ); and Mr. Maier is a citizen of Germany. Item2(d) Title of Class of Securities. Ordinary Shares, no

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on Read The Filing